4.6 Article

GP5+/6+ SYBR Green methodology for simultaneous screening and quantification of human papillomavirus

Journal

JOURNAL OF CLINICAL VIROLOGY
Volume 45, Issue 2, Pages 90-95

Publisher

ELSEVIER
DOI: 10.1016/j.jcv.2009.03.020

Keywords

Human papillomavirus; Screening; Viral load; SYBR Green; Real-time PCR

Categories

Funding

  1. CAPES, Brazilian Government [2184-07-9]

Ask authors/readers for more resources

Background: Detection and quantification of human papillomavirus (HPV) may help in predicting the evolution of HPV infection and progression of associated lesions. Objectives: We propose a novel protocol using consensus primers GP5+/6+ in a SYBR Green quantitative real-time (Q-RT) polymerase chain reaction (PCR). The strategy permits screening for HPV infection and viral load quantification simultaneously. Study design: DNA from 153 archived cervical samples, previously tested for HPV detection by GP5+/6+ PCR and typed by EIA-RLB (enzyme immunoassay-reverse line blot) or sequence analysis, was analysed using SYBR Green Q-RT PCR. Melting temperature assay (T-m) and cycle threshold (C-t) were used to evaluate HPV positivity and viral load. The T-m in the range of 77-82 degrees C was considered to be positive for HPV-DNA. HPV results generated through GP5+/6+ conventional PCR were considered the gold standard against which sensitivity and specificity of our assay were measured. Results: Out of 104 HPV positive samples, 100 (96.2%) were also determined as positive by SYBR Green Q-RT PCR; of the 49 HPV-negative samples, all were determined as negative. There was an excellent positivity agreement (K = 0.94) between the SYBR Green Q-RT and the previous methods employed. The specificity and sensitivity were 100% and 96.2%, respectively. Comparison of SYBR Green Q-RT and TaqMan oligo-probe technologies gave an excellent concordance (pc = 0.95) which validated the proposed strategy. Conclusions: We propose a sensitive and easy-to-perform technique for HPV screening and viral load quantification simultaneously. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Judith V. M. G. Bovee, Fleur Webster, Fernanda Amary, Daniel Baumhoer, J. L. (Hans) Bloem, Julia A. Bridge, Justin M. M. Cates, Enrique de Alava, Angelo Paolo Dei Tos, Kevin B. Jones, Annabelle Mahar, G. Petur Nielsen, Alberto Righi, Andrew J. Wagner, Akihiko Yoshida, Christopher D. M. Fletcher

Summary: This study presents international consensus-based datasets for the pathology reporting of bone sarcoma biopsy and resection specimens. These datasets were developed under the ICCR and aim to improve the quality and standardization of pathology reporting, thus enhancing the management of bone sarcoma patients.

HISTOPATHOLOGY (2023)

Correction Multidisciplinary Sciences

The repertoire of mutational signatures in human cancer (vol 578, pg 94, 2020)

Ludmil B. Alexandrov, Jaegil Kim, Nicholas J. Haradhvala, Mi Ni Huang, Alvin Wei Tian Ng, Yang Wu, Arnoud Boot, Kyle R. Covington, Dmitry A. Gordenin, Erik N. Bergstrom, S. M. Ashiqul Islam, Nuria Lopez-Bigas, Leszek J. Klimczak, John R. McPherson, Sandro Morganella, Radhakrishnan Sabarinathan, David A. Wheeler, Ville Mustonen, Gad Getz, Steven G. Rozen, Michael R. Stratton

NATURE (2023)

Correction Multidisciplinary Sciences

Genomic basis for RNA alterations in cancer (vol 578, pg 129, 2020)

Claudia Calabrese, Natalie R. Davidson, Deniz Demircioglu, Nuno A. Fonseca, Yao He, Andre Kahles, Kjong-Van Lehmann, Fenglin Liu, Yuichi Shiraishi, Cameron M. Soulette, Lara Urban, Liliana Greger, Siliang Li, Dongbing Liu, Marc D. Perry, Qian Xiang, Fan Zhang, Junjun Zhang, Peter Bailey, Serap Erkek, Katherine A. Hoadley, Yong Hou, Matthew R. Huska, Helena Kilpinen, Jan O. Korbel, Maximillian G. Marin, Julia Markowski, Tannistha Nandi, Qiang Pan-Hammarstrom, Chandra Sekhar Pedamallu, Reiner Siebert, Stefan G. Stark, Hong Su, Patrick Tan, Sebastian M. Waszak, Christina Yung, Shida Zhu, Philip Awadalla, Chad J. Creighton, Matthew Meyerson, B. F. Francis Ouellette, Kui Wu, Huanming Yang, Alvis Brazma, Angela N. Brooks, Jonathan Goeke, Gunnar Raetsch, Roland F. Schwarz, Oliver Stegle, Zemin Zhang

NATURE (2023)

Correction Multidisciplinary Sciences

Patterns of somatic structural variation in human cancer genomes (vol 578, pg 112, 2020)

Yilong Li, Nicola D. Roberts, Jeremiah A. Wala, Ofer Shapira, Steven E. Schumacher, Kiran Kumar, Ekta Khurana, Sebastian Waszak, Jan O. Korbel, James E. Haber, Marcin Imielinski, Joachim Weischenfeldt, Rameen Beroukhim, Peter J. Campbell

NATURE (2023)

Article Immunology

CK2β-regulated signaling controls B cell differentiation and function

Laura Quotti Tubi, Elisa Mandato, Sara Canovas Nunes, Arash Arjomand, Fortunato Zaffino, Sabrina Manni, Alessandro Casellato, Paolo Macaccaro, Nicola Vitulo, Sara Zumerle, Odile Filhol, Brigitte Boldyreff, Christian W. Siebel, Antonella Viola, Giorgio Valle, Federica Mainoldi, Stefano Casola, Valeria Cancila, Alessandro Gulino, Claudio Tripodo, Marco Pizzi, Angelo Paolo Dei Tos, Livio Trentin, Gianpietro Semenzato, Francesco Piazza

Summary: The role of CK2 in B-cell development and activation is not well understood. Using a CK2 beta(KO) mouse model, we found that CK2 beta(KO) mice exhibit increased marginal zone (MZ) B cells and reduced follicular B cells, suggesting a role for CK2 in the regulation of BCR and NOTCH2 signaling pathways. Further analysis revealed enhanced activation of the NOTCH2 pathway in CK2 beta(KO) mice, supporting MZ B-cell development. Additionally, CK2 beta(KO) mice showed alterations in immune response and B-cell activation processes. In vitro assays demonstrated impaired signaling downstream of BCR, Toll-like receptor, CD40, and IL-4R in B cells lacking CK2 beta.

FRONTIERS IN IMMUNOLOGY (2023)

Review Oncology

Clear cell sarcoma: state-of-the art and perspectives

Laureline Wetterwald, Nicolo Riggi, Anastasios Kyriazoglou, Giovanni Dei Tos, Angelo Dei Tos, Antonia Digklia

Summary: Clear cell sarcoma (CCS) is an ultrarare soft tissue sarcoma with a poor prognosis. The standard treatment for localized CCS is surgical excision with or without radiotherapy. The treatment options for unresectable CCS are limited despite the lack of scientific evidence.

EXPERT REVIEW OF ANTICANCER THERAPY (2023)

Article Hematology

Higher accuracy of surgical over core needle biopsy for the diagnosis of lymphoproliferative disorders

Marco Pizzi, Marta Sbaraglia, Luca Dal Santo, Debora De Bartolo, Luisa Santoro, Federico Scarmozzino, Lara Mussolin, Marta Pillon, Francesco Piazza, Livio Trentin, Angelo Paolo Dei Tos

Summary: This study retrospectively reviewed 43 paired LNCB/SEB samples and found that LNCB had limited diagnostic value, with a significant number of diagnostic errors and delay. Therefore, SEB should still be considered as the gold standard procedure.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2023)

Review Biochemistry & Molecular Biology

An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence

Lisa Padroni, Laura De Marco, Lucia Dansero, Valentina Fiano, Lorenzo Milani, Paolo Vasapolli, Luca Manfredi, Saverio Caini, Claudia Agnoli, Fulvio Ricceri, Carlotta Sacerdote

Summary: Breast cancer is a multifactorial disease influenced by genetic predisposition and environmental exposures. MicroRNAs, a group of small non-coding RNA molecules, may act as tumor suppressor genes or oncogenes and play a role in cancer risk. A systematic review and meta-analysis were conducted to identify circulating microRNAs associated with breast cancer diagnosis, with emphasis on methodological issues. The analysis included 75 studies, and meta-analysis was performed for microRNAs analyzed in at least three independent studies. The study found that MIR21, MIR155, and MIR10b were differentially expressed in breast cancer patients compared to healthy controls, but there was little consistency among the included studies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pathology

PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2-BC patients with residual disease after neoadjuvant chemotherapy: a cohort study

Federica Miglietta, Valentina Carraro, Ottavia Amato, Gaia Griguolo, Michele Bottosso, Giada Munari, Giovanni Zarrilli, Marcello Lo Mele, Caterina Barbieri, Angelo Paolo Dei Tos, Valentina Guarneri, Maria Vittoria Dieci, Matteo Fassan

Summary: This study aims to track the dynamics of the PI3K/PTEN/mTOR pathway in HR+/HER2- breast cancer patients receiving neoadjuvant chemotherapy. The results show that this pathway is highly dynamic and may play a crucial role in shaping the molecular landscape of breast cancer with residual disease after chemotherapy.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Surgery

IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort study

Gaya Spolverato, Matteo Fassan, Giulia Capelli, Melania Scarpa, Silvia Negro, Valentina Chiminazzo, Andromachi Kotsafti, Imerio Angriman, Michela Campi, Ottavia De Simoni, Cesare Ruffolo, Stepanyan Astghik, Chiara Vignotto, Federico Scognamiglio, Giulia Becherucci, Giorgio Rivella, Francesco Marchegiani, Luca Facci, Francesca Bergamo, Stefano Brignola, Gianluca Businello, Vincenza Guzzardo, Luca Dal Santo, Roberta Salmaso, Marco Massani, Anna Pozza, Ivana Cataldo, Tommaso Stecca, Angelo Paolo Dei Tos, Vittorina Zagonel, Pierluigi Pilati, Boris Franzato, Antonio Scapinello, Giovanni Pirozzolo, Alfonso Recordare, Roberto Merenda, Giovanni Bordignon, Silvio Guerriero, Chiara Romiti, Giuseppe Portale, Chiara Cipollari, Maurizio Zizzo, Andrea Porzionato, Marco Agostini, Francesco Cavallin, Barbara Di Camillo, Romeo Bardini, Isacco Maretto, Ignazio Castagliuolo, Salvatore Pucciarelli, Marco Scarpa

Summary: This study evaluated the sex differences in the immune microenvironment of rectal cancer patients and found that male patients had more frequent oncogene mutations associated with lower expression of T-cell activation genes, while female patients had more Th1 cells and cytotoxic T cells in the healthy mucosa, suggesting a potentially better immune response to the tumor.

INTERNATIONAL JOURNAL OF SURGERY (2023)

Review Pediatrics

Fetal Lung Interstitial Tumor (FLIT): Review of The Literature

Silvia Perin, Ivana Cataldo, Francesca Baciorri, Luisa Santoro, Angelo Paolo Dei Tos, Maria Guido, Paola Midrio

Summary: Fetal lung interstitial tumor (FLIT) is a rare pediatric lung tumor that can be mistaken for other lung neoplasms and congenital pulmonary malformations (cPAM) based on radiological features. A review of the literature found 21 cases of FLIT, with only 3 cases having a prenatal diagnosis. Surgery, usually lobectomy, was performed at an average age of 31 days, and there were no reported complications or disease recurrence during a mean follow-up of 49 months. Histology and immunohistochemistry can differentiate FLIT from other lung tumors with poor prognosis.

CHILDREN-BASEL (2023)

Letter Cell Biology

Morphological progression of biphenotypic sinonasal sarcoma to high-grade sarcoma at 7?years from onset

Elena Bellan, Carlo Patriarca, Angelo P. Dei Tos, Marta Sbaraglia

HISTOPATHOLOGY (2023)

Article Cell Biology

Fusion transcriptome profiling defines the monoclonal origin of multifocal epithelioid haemangioma of bone

Costantino Errani, Ilaria De Benedictis, Alberto Righi, Beatrice Valenti, Elisa Del Savio, Davide Baldazzi, Stefania Benini, Marta Sbaraglia, Brayan Vega Jimenez, Daniel Vanel, Davide Maria Donati, Angelo Paolo Dei Tos, Roberta Maestro

Summary: This retrospective study analyzed the clinical behavior and biology of epithelioid hemangioma (EH) of bone. The results showed that multifocal lesions of bone EH are clonally related, indicating the spread of a same neoplastic clone rather than simultaneous independent tumors. This finding contradicts the benign clinical course of EH and suggests that tumor dissemination in bone EH may be a phenomenon of passive spreading.

HISTOPATHOLOGY (2023)

Article Pathology

Cost analysis of archives in the pathology laboratories: from safety to management

Albino Eccher, Angelo Paolo Dei Tos, Aldo Scarpa, Vincenzo L'Imperio, Enrico Munari, Giancarlo Troncone, Antonio Giuseppe Naccarato, Davide Seminati, Fabio Pagni

Summary: Despite reluctance to invest and challenges in estimating supporting costs, optimizing archives is becoming a hot topic in pathology laboratory management. Historically, archives were inadequate for securely storing and organizing tissue specimens, leading to risks for patients' health and legal consequences for pathologists.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Review Oncology

Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies

J. -y. Blay, M. von Mehren, R. L. Jones, J. Martin-Broto, S. Stacchiotti, S. Bauer, H. Gelderblom, D. Orbach, N. Hindi, A. Dei Tos, M. Nathenson

Summary: Synovial sarcoma is a rare and aggressive disease, accounting for 5%-10% of all soft tissue sarcomas. Diagnosis is often challenging, but referral to a specialist center is crucial for optimal outcomes. Treatment strategies for localized disease include surgery, radiotherapy, and chemotherapy, while advanced disease has a poor prognosis and requires novel management strategies such as targeted agents and immunotherapies.

ESMO OPEN (2023)

No Data Available